Multi-cancer early detection test in symptomatic patients referred for cancer investigation in England and Wales (SYMPLIFY): a large-scale, observational cohort study - The Lancet Oncology

Jeffrey Venstrom, M.D. on LinkedIn: #esmo22

Early detection of cancer

A spectroscopic liquid biopsy for the earlier detection of multiple cancer types

Multi-cancer early detection test in symptomatic patients referred for cancer investigation in England and Wales (SYMPLIFY): a large-scale, observational cohort study - The Lancet Oncology

Cancer care innovation: The multi-cancer early detection test leaders are implementing for detection

Protein biomarkers and alternatively methylated cell-free DNA detect early stage pancreatic cancer

Circulating cell-free DNA-based multi-cancer early detection: Trends in Cancer

Estimating the population health impact of a multi-cancer early detection genomic blood test to complement existing screening in the US and UK

Large-scale study on early cancer detection in patients in Europe